GemmaBio raised $34M in a Series A funding round to commercialize gene therapies for rare diseases.
Amount Raised
$34 Million
Round Type
Series A
PhiladelphiaBiotechnologyHealth CareTherapeuticsInvestors
Description
GemmaBio has successfully raised $34 million in its Series A funding round. This investment will be utilized to further develop and commercialize innovative gene therapies aimed at treating rare diseases.
Quick answer
GEMMABio raised $34 Million in a Series A round, dated December 23, 2024. Investors: Savanne Life Sciences, Earlybird Venture Capital, Bioluminescence Ventures and Double Point Ventures. GEMMABio is based in Philadelphia, Pennsylvania, United States.
- How much did GEMMABio raise?
- GEMMABio raised $34 Million in a Series A round on December 23, 2024.
- Who invested in GEMMABio?
- Savanne Life Sciences, Earlybird Venture Capital, Bioluminescence Ventures and Double Point Ventures are named as investors in this round.
- What does GEMMABio do?
- GEMMABiotherapeutics, also known as GEMMABio, is a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson.
- Where is GEMMABio based and how big is it?
- GEMMABio is based in Philadelphia, Pennsylvania, United States. Fundz records about 56 employees.
- Who are the decision-makers at GEMMABio?
- Fundz holds 1 contact at GEMMABio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as GEMMABio that raised within 45 days of this round, from Fundz verified event records.
- Miist Therapeutics raised $7M (Seed) on February 5, 2025.
- Entos Pharmaceuticals raised $4M (Seed) on February 5, 2025.
- AdvanCell raised $112M (Series C) on February 3, 2025.
- Lactiga raised an undisclosed amount (Grant) on February 3, 2025.
- Aplagon raised $7.6M (Pre-Seed) on February 3, 2025.
- Vetigenics raised $6M (Seed) on February 3, 2025.
Who to call at GEMMABio, and when
A new round usually means GEMMABio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GEMMABio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GEMMABio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GEMMABio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GEMMABio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGEMMABio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.